January 6, 2016
LivaNova: “FDA’s Warning Letter can be resolved without material impact on financial results”
LivaNova said that FDA’s Warning Letter can be resolved without a material impact on financial results.
Pharmaceuticals, Biotechnology and Life Sciences
Tag: featured
January 6, 2016
Glenmark’s generic Multaq tablets wait for final FDA approval after tentative
Glenmark Pharmaceuticals Inc., has been granted tentative approval by the USFDA for its Dronedarone Tablets, 400 mg, the generic version…
January 5, 2016
Suven’s products gets three patent grants; from Canada, ARIPO, and South Korea
Suven Life Sciences Ltd has announced that the grand of one product patent from Canada, one from ARIPO and one from South Korea corresponding to the New Chemical Entities for the treatment of disorders associated with Neurodegenerative diseases and these Patents are valid through 2030.
January 5, 2016
Midatech in vaccines collaboration with Emergex
Midatech Pharma, the international specialty pharmaceutical company focused on developing and commercialising products in oncology and other therapeutic areas, has entered into a licensing agreement with Emergex Vaccines Limited, a private UK biotechnology company focused on infectious diseases utilising Midatech’s gold nanoparticle technology.
December 31, 2015
Brooks Laboratories’ new manufacturing unit in Vadodra to kick off production in 3 months
Brooks Laboratories’ new manufacturing unit in Vadodra to kick off production in 3 months
December 30, 2015
Dr. Reddy’s re-launches generic version of Nexium
India’s Dr. Reddy’s has re-launched its Esomeprazole Magnesium Delayed-Release Capsules, which is a therapeutic equivalent generic version of Nexium Delayed-Release…
December 29, 2015
Nectar Lifesciences appoints Additional Independet Director
Nectar Lifesciences appoints Additional Independet Director
December 28, 2015
Valeant CEO Pearson remains hospitalised for pneumonia – Bloomberg
Valeant Pharmaceuticals International Inc Chief Executive J. Michael Pearson has been moved to another hospital where he is being treated for a severe case of pneumonia
December 28, 2015
Jochen Gann BI’s first director of Hikma
Hikma Board has appointed Dr. Jochen Gann as BI’s first nominated director.
December 22, 2015
FDA approves India’s Aurobindo’s generic version of Alcon’s Patanol
Aurobindo Pharma Limited has received final approval from the US Food & Drug Administration (USFDA) to manufacture and market Olopatadine Hydrochloride Ophthalmic Solution USP, 0.1% which makes the product is ready for launch.